Institutional Ownership
Precision Biosciences Inc
CUSIP 74019P207COM NEWDTILQ1 2026
13D / 13G Filings
24
Schedule 13D/13G on record
Beneficial Filers
16
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
75
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
24 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Tang Capital Management, LLC | 13G/A | — | — | SEC |
| 2 | Feb 17, 2026 | Lynx1 Capital Management LP | 13G/A | 4.1% | 993.9K | SEC |
| 3 | Feb 13, 2026 | Bleichroeder LP | 13G/A | 8.2% | 1.90M | SEC |
| 4 | Feb 10, 2026 | Octagon Capital Advisors LP | 13G | 10.0% | 2.33M | SEC |
| 5 | Jan 27, 2026 | Aberdeen Group PLC | 13G | 8.9% | 2.14M | SEC |
| 6 | Jan 22, 2026 | Empery Asset Management, LP | 13G | 10.0% | 2.30M | SEC |
| 7 | Nov 14, 2025 | Lynx1 Capital Management LP | 13G/A | 8.8% | 1.04M | SEC |
| 8 | Aug 14, 2025 | Bleichroeder LP | 13G | 9.7% | 1.07M | SEC |
| 9 | Aug 14, 2025 | Readout Capital, LP | 13G/A | 9.4% | 1.12M | SEC |
| 10 | Aug 6, 2025 | Aquilo Capital, L.P. | 13G/A | — | — | SEC |
14 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Precision Biosciences Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Octagon Capital Advisors LP | 2.24M | $12.30M |
| 2 | Aberdeen Group PLC | 2.23M | $12.27M |
| 3 | Empery Asset Management, LP | 1.97M | $10.83M |
| 4 | Bleichroeder LP | 1.66M | $9.14M |
| 5 | Boothbay Fund Management, LLC | 1.07M | $5.86M |
| 6 | Driehaus Capital Management LLC | 995.4K | $5.47M |
| 7 | Lynx1 Capital Management LP | 985.1K | $5.42M |
| 8 | Affinity Asset Advisors, LLC | 597.9K | $3.29M |
| 9 | Marshall Wace, LLP | 415.7K | $2.29M |
| 10 | Two Sigma Investments, LP | 307.8K | $1.69M |